首页> 外文期刊>Journal of the American Chemical Society >Membrane Transporters For Anions That Use A Relay Mechanism
【24h】

Membrane Transporters For Anions That Use A Relay Mechanism

机译:使用中继机制的阴离子膜转运蛋白

获取原文
获取原文并翻译 | 示例
       

摘要

Synthetic bilayer membrane transporters are usually classified mechanistically as mobile carriers or as ion channels. A mobile carrier associates with a target ion to form a discrete supramolecular complex that diffuses across the membrane; whereas, an ion channel is a relatively immobile structure that spans the bilayer and allows a continuous flow of ions. In recent years there has been increased effort to design synthetic membrane transport systems for anions, especially Cl~-. One of the long-term goals of this work is to create transporter replacement therapies that can alleviate the symptoms of diseases caused by diminished levels of endogenous Cl~- transport (e.g., cystic fibrosis). The field of anion transport is still in its early stages with most published studies focusing on fundamental transport studies using model bilayer membranes. In terms of transporter designs, nearly all have been highly lipophilic compounds that partition strongly and nonselectively into any membrane.5 However, next-generation designs must begin to address the requirements for pharmaceutical success, including the following formulation features: (a) acceptable solubility in physiological solution, (b) appropriate cell targeting and subsequent membrane partitioning, (c) lengthy residence time in the apical plasma membrane of target cells. Suitably designed amphiphilic transporters are likely to exhibit these desirable properties; however, it is quite challenging to design amphiphilic transporters that operate by carrier or ion channel mechanisms. This quandary has prompted us to design a new type of membrane transporter that operates by a relay mechanism.
机译:合成双层膜转运蛋白通常在机械上分类为移动载体或离子通道。移动载体与目标离子缔合形成离散的超分子复合物,该复合物扩散穿过整个膜。然而,离子通道是横跨双层的相对固定的结构,并允许离子连续流动。近年来,人们加大了设计阴离子,尤其是Cl-的合成膜传输系统的努力。这项工作的长期目标之一是创建转运蛋白替代疗法,以减轻因内源性Cl-转运水平降低(例如,囊性纤维化)而引起的疾病症状。阴离子运输领域仍处于早期阶段,大多数已发表的研究都集中在使用模型双层膜的基本运输研究上。就转运蛋白的设计而言,几乎所有化合物都是高度亲脂性的化合物,它们可以强烈地且非选择性地分配到任何膜中。5但是,下一代设计必须开始满足药物成功的要求,包括以下制剂特性:(a)可接受的溶解度在生理溶液中,(b)适当的细胞靶向和随后的膜分区,(c)在靶细胞顶质膜中的停留时间长。适当设计的两亲性转运蛋白可能表现出这些理想的特性。然而,设计通过载流子或离子通道机制运行的两亲性转运蛋白是非常具有挑战性的。这种困境促使我们设计出一种新型的由中继机构运行的膜转运蛋白。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号